Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 41.4 EUR Market Closed
Market Cap: 1.6B EUR
Have any thoughts about
Biotest AG?
Write Note

Intrinsic Value

The intrinsic value of one BIO stock under the Base Case scenario is 32.17 EUR. Compared to the current market price of 41.4 EUR, Biotest AG is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIO Intrinsic Value
32.17 EUR
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Biotest AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for BIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BIO?
Bearish
Neutral
Bullish

Fundamental Analysis

41.4 EUR
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Biotest AG
DE
Biotechnology
Market Cap
1.6B EUR
IPO
Oct 14, 1987
Employees
1 967
Germany
Market Cap
1.6B EUR
Industry
Biotechnology
IPO
Oct 14, 1987
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Biotest AG

Provide an overview of the primary business activities
of Biotest AG.

What unique competitive advantages
does Biotest AG hold over its rivals?

What risks and challenges
does Biotest AG face in the near future?

Summarize the latest earnings call
of Biotest AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biotest AG.

Provide P/S
for Biotest AG.

Provide P/E
for Biotest AG.

Provide P/OCF
for Biotest AG.

Provide P/FCFE
for Biotest AG.

Provide P/B
for Biotest AG.

Provide EV/S
for Biotest AG.

Provide EV/GP
for Biotest AG.

Provide EV/EBITDA
for Biotest AG.

Provide EV/EBIT
for Biotest AG.

Provide EV/OCF
for Biotest AG.

Provide EV/FCFF
for Biotest AG.

Provide EV/IC
for Biotest AG.

Show me price targets
for Biotest AG made by professional analysts.

What are the Revenue projections
for Biotest AG?

How accurate were the past Revenue estimates
for Biotest AG?

What are the Net Income projections
for Biotest AG?

How accurate were the past Net Income estimates
for Biotest AG?

What are the EPS projections
for Biotest AG?

How accurate were the past EPS estimates
for Biotest AG?

What are the EBIT projections
for Biotest AG?

How accurate were the past EBIT estimates
for Biotest AG?

Compare the revenue forecasts
for Biotest AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biotest AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biotest AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biotest AG compared to its peers.

Compare the P/E ratios
of Biotest AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Biotest AG with its peers.

Analyze the financial leverage
of Biotest AG compared to its main competitors.

Show all profitability ratios
for Biotest AG.

Provide ROE
for Biotest AG.

Provide ROA
for Biotest AG.

Provide ROIC
for Biotest AG.

Provide ROCE
for Biotest AG.

Provide Gross Margin
for Biotest AG.

Provide Operating Margin
for Biotest AG.

Provide Net Margin
for Biotest AG.

Provide FCF Margin
for Biotest AG.

Show all solvency ratios
for Biotest AG.

Provide D/E Ratio
for Biotest AG.

Provide D/A Ratio
for Biotest AG.

Provide Interest Coverage Ratio
for Biotest AG.

Provide Altman Z-Score Ratio
for Biotest AG.

Provide Quick Ratio
for Biotest AG.

Provide Current Ratio
for Biotest AG.

Provide Cash Ratio
for Biotest AG.

What is the historical Revenue growth
over the last 5 years for Biotest AG?

What is the historical Net Income growth
over the last 5 years for Biotest AG?

What is the current Free Cash Flow
of Biotest AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biotest AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biotest AG

Current Assets 704.5m
Cash & Short-Term Investments 37.8m
Receivables 171.8m
Other Current Assets 494.9m
Non-Current Assets 642.2m
Long-Term Investments 26.5m
PP&E 573.9m
Intangibles 16.4m
Other Non-Current Assets 25.4m
Current Liabilities 277.1m
Accounts Payable 58.1m
Other Current Liabilities 219m
Non-Current Liabilities 542.1m
Long-Term Debt 432m
Other Non-Current Liabilities 110.1m
Efficiency

Earnings Waterfall
Biotest AG

Revenue
707m EUR
Cost of Revenue
-467m EUR
Gross Profit
240m EUR
Operating Expenses
-150.8m EUR
Operating Income
89.2m EUR
Other Expenses
-20.7m EUR
Net Income
68.5m EUR

Free Cash Flow Analysis
Biotest AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIO Profitability Score
Profitability Due Diligence

Biotest AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
47/100
Profitability
Score

Biotest AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

BIO Solvency Score
Solvency Due Diligence

Biotest AG's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
43/100
Solvency
Score

Biotest AG's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIO Price Targets Summary
Biotest AG

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one BIO stock?

The intrinsic value of one BIO stock under the Base Case scenario is 32.17 EUR.

Is BIO stock undervalued or overvalued?

Compared to the current market price of 41.4 EUR, Biotest AG is Overvalued by 22%.

Back to Top